Warning letter
Staten Island University Hospital: warning letter of Dec 20, 1999
FDA warning letter UCM067962 · New York District Office
Key facts
| Reference number | UCM067962 |
|---|---|
| Company | Staten Island University Hospital |
| Subject | Blood & Blood Components |
| Issue date | Dec 20, 1999 |
| Posted date | Dec 20, 1999 |
| Issuing office | New York District Office |
| Product type | Unknown |
| CFR sections cited | 606, 640.4, 606.160(b)(3)(iv), 606.160(b)(5), 640.4(f), 640.34(g)(2), 606.100(b), 606.160(e) |
| Country | 3 |
| Inspection city | Staten Island |
| Inspection ZIP | 10305-3436 |
| Inspection start date | Sep 27, 1999 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: